Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap J van Doormaal

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Cancer|June 17, 2006
Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trialHelga J Droogendijk, Hanneke J C Kluin-Nelemans, Jaap J van Doormaal, et al.
Wiener Klinische Wochenschrift|June 9, 2005
The European Competence Network on Mastocytosis (ECNM)Peter Valent, Michel Arock, Stephan C Bischoff, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Cancer|June 17, 2006
Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trialHelga J Droogendijk, Hanneke J C Kluin-Nelemans, Jaap J van Doormaal, et al.
Wiener Klinische Wochenschrift|June 9, 2005
The European Competence Network on Mastocytosis (ECNM)Peter Valent, Michel Arock, Stephan C Bischoff, et al.
Pageof 1